Citations

Clear

2117 citation(s) found for "Mayo, Steven".

An exploration into patient preference for injectable therapy over surgery in the treatment of female urinary incontinence
Petrou, Steven P. , Lisson, Scott W., Lightner, Deborah J., Crook, Julia E.

Mayo Clinic

International braz j urol | January 17, 2007 | Volume: 32 | Issue: 5 | Pages: 578-582

10.1590/s1677-55382006000500014 | PMID 17081330 Get It

Development of a Cathartic-Free Colorectal Cancer Screening Test Using Virtual Colonoscopy: A Feasibility Study
Carston, Michael J., Wentz, Robert J., Anderson, Steven M. , Johnson, C. Daniel, Johnson, Kristina T. , Manduca, Armando

Mayo Clinic

American Journal of Roentgenology | December 19, 2006 | Volume: 188 | Issue: 1 | Pages: W29-W36

10.2214/ajr.05.1484 | PMID 17179324 Get It

Phase III Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone: NCCTG N03C5
Loprinzi, Charles L. , Kugler, John W., Barton, Debra L. , Dueck, Amylou C. , Tschetter, Loren K., Nelimark, Robert A., Balcueva, Ernie, Burger, Kelli N. , Novotny, Paul J. , Carlson, Mark D., Duane, Steven F., Corso, Steven, Johnson, David B., Jaslowski, Anthony J., Dueck, A. C.

Mayo Clinic

Journal of Clinical Oncology | December 5, 2006 | Volume: 25 | Issue: 3 | Pages: 308-312

10.1200/jco.2006.07.5390 | PMID 17146104 Get It

Purpose Despite the utility of newer antidepressants for alleviating hot flashes, antidepressants do not work adequately enough in many patients. Gabapentin is a nonhormonal agent that also can reduce hot flashes. No data have been available to address whether the combination of both agents would more effectively alleviate hot flashes, compared with gabapentin alone, in patients with inadequate hot flash control with an antidepressant alone. Patients and Methods This was a randomized trial in which 118 patients with inadequate hot flash control on an antidepressant were randomly assigned to receive both an antidepressant and gabapentin versus being weaned off the antidepressant and receiving gabapentin alone. Patients were observed for 5 weeks (including a baseline week in which patients continued on their current antidepressant without gabapentin) during which time they completed validated daily hot flash diaries. Results Ninety-one patients provided complete data at the 5-week assessment. Regardless of whether or not the antidepressant was continued when gabapentin was started, there was an approximately 50% median reduction in hot flash frequencies (54%; 95% CI, 34% to 70% for combined treatment v 49%; 95% CI, 26% to 58% for gabapentin alone) and scores (56%; 95% CI, 26% to 71% for combined treatment v 60%; 95% CI, 33% to 73% for gabapentin alone). Conclusion Gabapentin seems to decrease hot flashes by approximately 50% in women with inadequate hot flash control who were using an antidepressant. This study saw no significant additional hot flash reduction from continuation of the antidepressant.
The Human Immunodeficiency Virus Type 1 Tat Protein EnhancesCryptosporidium parvum-Induced Apoptosis in Cholangiocytes via a Fas Ligand-Dependent Mechanism
O’Hara, Steven P. , Small, Aaron J., Nelson, Jeremy B., Badley, Andrew D. , Chen, Xian‐Ming , Gores, Gregory J. , LaRusso, Nicholas F. , Badley, Andrew D

Mayo Clinic

Infection and Immunity | November 22, 2006 | Volume: 75 | Issue: 2 | Pages: 684-696

10.1128/iai.01348-06 | PMID 17118988 Get It

ABSTRACTWhileCryptosporidium parvuminfection of the intestine has been reported in both immunocompetent and immunocompromised individuals, biliary infection is seen primarily in adult AIDS patients and is associated with development of AIDS cholangiopathy. However, the mechanisms of pathogen-induced AIDS cholangiopathy remain unclear. Since we previously demonstrated that the Fas/Fas ligand (FasL) system is involved in paracrine-mediatedC. parvumcytopathicity in cholangiocytes, we also tested the potential synergistic effects of human immunodeficiency virus type 1 (HIV-1) transactivator of transcription (Tat)-mediated FasL regulation onC. parvum-induced apoptosis in cholangiocytes by semiquantitative reverse transcription-PCR, immunoblotting, immunofluorescence analysis, and immunogold electron microscopy. H69 cells do not express CXCR4 and CCR5, which are receptors required for direct HIV-1 viral infection. However, recombinant biologically active HIV-1-associated Tat protein increased FasL expression in the cytoplasm of cholangiocytes without a significant increase in apoptosis. We found thatC. parvum-induced apoptosis was associated with translocation of intracellular FasL to the cell membrane surface and release of full-length FasL from infected H69 cells. Tat significantly (P< 0.05) increasedC. parvum-induced apoptosis in bystander cells in a dose-dependent manner. Moreover, Tat enhanced bothC. parvum-induced FasL membrane translocation and release of full-length FasL. In addition, the FasL neutralizing antibody NOK-1 and the caspase-8 inhibitor Z-IETD-fmk both blockedC. parvum-induced apoptosis in cholangiocytes. The data demonstrated that HIV-1 Tat enhancesC. parvum-induced cholangiocyte apoptosis via a paracrine-mediated, FasL-dependent mechanism. Our results suggest that concurrent active HIV replication, with associated production of Tat protein, andC. parvuminfection synergistically increase cholangiocyte apoptosis and thus jointly contribute to AIDS-related cholangiopathies.
Sex differences in the epidemiology and outcomes of heart disease: population-based trends
Roger, V Vl, Jacobsen, Steven J. , Weston, Susan A., Gabriel, S. E.

Mayo Clinic

Lupus | November 2, 2006 | Volume: 8 | Issue: 5 | Pages: 346-350

10.1177/096120339900800503 | PMID 10455511 Get It

We examined trends in heart disease (HD) mortality and the delivery of cardiac in Olmsted County, MN. Between 1979 and 1994, women experienced 51% of the total number of HD (ICD9 codes 390 — 398,402,404 — 429) deaths (3095). Age-adjusted HD mortality rate declined from 123 per 100,000 (95%CI 102, 144) in 1979 to 81 (67,95) in 1994. The risk ratio (RR) of HD death in 1994 compared to 1979 was 0.69 for women vs 0.53 for men (P = 0.06). This equates to a decline in HD mortality of 2.5%=y in women and 4.2%=y in men. The decline in HD mortality was less pronounced in older age groups (P < 0.001), reflecting a shift of the burden of HD towards women and the elderly. Compared to men, there was less use of stress tests among women, of cardiology visits after stress testing, and of cardiac procedures among women presenting to the emergency room with unstable angina. Further studies are needed to examine causal links between these trends.
Truncating Variants in p53AIP1 Disrupting DNA Damage–Induced Apoptosis Are Associated with Prostate Cancer Risk
Wang, Fengwei , Taniguchi, Ken, Seelan, Ratnam S. , Zarfas, Katherine E., McDonnell, Shannon K. , Qian, Chiping , Lu, Youyong , Shridhar, Viji , Tindall, Donald J., Beebe‐Dimmer, Jennifer , Cooney, Kathleen A. , Isaacs, William B., Jacobsen, Steven J. , Schaid, Daniel J. , Thibodeau, Stephen N. , Wang, Xianshu , Wang, Liang , Pan, Kai‐Feng , Couch, Fergus J. , Liu, Wanguo , McDonnell, Shannon K

Mayo Clinic

Cancer Research | November 2, 2006 | Volume: 66 | Issue: 21 | Pages: 10302-10307

10.1158/0008-5472.can-06-0638 | PMID 17079449 Get It

Abstract Germ line mutations in several genes (BRCA1, BRCA2, and CHEK2) whose products are involved in the DNA damage–signaling pathway have been implicated in prostate cancer risk. To identify additional genes in this pathway that might confer susceptibility to this cancer, we analyzed a recently identified DNA damage–response gene, p53AIP1 (a gene encoding for p53-regulated apoptosis-inducing protein 1), for genetic variants in prostate cancer. Five novel germ line variants were identified. The two truncating variants (Ser32Stop and Arg21insG) were found in 3% (4 of 132) of unselected prostate tumor samples. Genotyping of the two variants in an additional 393 men with sporadic prostate cancer showed a frequency of 3.1% (12 of 393) in contrast to 0.6% (2 of 327) in 327 unaffected men (Fisher's exact test, P = 0.018), with an odds ratio (OR) of 5.1 [95% confidence interval (95% CI), 1.1-23.0]. In addition, two of six tumors carrying the truncating variants were associated with loss of heterozygosity of the wild-type alleles, suggesting that p53AIP1 may act as a tumor suppressor. We also showed that the truncated p53AIP1 was unable to induce apoptosis and suppress cell growth in HeLa and COS-7 cells. These results suggest that loss-of-function variants in p53AIP1 associated with the risk of sporadic prostate cancer and further support the concept that the genetic defects in the DNA damage–response genes play an important role in the development of prostate cancer. (Cancer Res 2006; 66(21): 10302-7)
Evolving Role of Chemotherapy in Resected Liver Metastases
Alberts, Steven R.

Mayo Clinic

Journal of Clinical Oncology | October 30, 2006 | Volume: 24 | Issue: 31 | Pages: 4952-4953

10.1200/jco.2006.07.9236 | PMID 17075111 Get It

Combined Prostate Brachytherapy and Short-Term Androgen Deprivation Therapy as Salvage Therapy for Locally Recurrent Prostate Cancer After External Beam Irradiation
Wong, William W. , Buskirk, Steven J., Schild, Steven E. , Prussak, Karin, Davis, Brian J. , Schild, Steven , Davis, Brian J

Mayo Clinic

Journal of Urology | October 26, 2006 | Volume: 176 | Issue: 5 | Pages: 2020-2024

10.1016/j.juro.2006.07.008 | PMID 17070243 Get It

Attenuation of CD8+ T-Cell Function by CD4+CD25+ Regulatory T Cells in B-Cell Non-Hodgkin's Lymphoma
Yang, Zhi‐Zhang, Novak, Anne J. , Ziesmer, Steven C., Ansell, Stephen M. , Witzig, Thomas E.

Mayo Clinic

Cancer Research | October 18, 2006 | Volume: 66 | Issue: 20 | Pages: 10145-10152

10.1158/0008-5472.can-06-1822 | PMID 17047079 Get It

AbstractThe underlying mechanisms by which tumor cells are resistant to CTL-mediated apoptosis are not clear. Using a human model of B-cell non-Hodgkin's lymphoma (B-cell NHL), we show that intratumoral Treg cells inhibit the proliferation and granule production of activated autologous infiltrating CD8+ T cells. Our results also show that degranulation and subsequent cytotoxic activity of infiltrating CD8+ T cells exposed to lymphoma B cells is completely attenuated by the presence of intratumoral Treg cells. Furthermore, we show that increased numbers of intratumoral Treg cells correlates with the number of CD8+ T cells in biopsy specimens from patients with B-cell NHL, supporting the in vitro findings that intratumoral Treg cells inhibit proliferation of infiltrating CD8+ T cells. Taken together, these data indicate that human lymphoma B cells are sensitive to autologous CTL-mediated cell death but are protected by the inhibitory function of intratumoral Treg cells. (Cancer Res 2006; 66(20): 10145-52)
THE IMPACT OF LIVER TRANSPLANT PROGRAMS ON ANESTHESIA PERSONNEL AND SERVICES
Spiess, B. D., Narbone, R. F., Rettke, Steven R., Ivankovich, A. D., McCarthy, Robert J.

Mayo Clinic

Anesthesiology | October 10, 2006 | Volume: 67 | Issue: 3 | Pages: A568-A568

10.1097/00000542-198709001-00568 Get It